Bioxcel Therapeutics, Inc. · NASDAQ:BTAI
Armistice Capital, LLC reported a 9.99% stake in Bioxcel Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 9.99% stake in Bioxcel Therapeutics, Inc., 4,997,275 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 4,997,275
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 4,997,275 |
| Steven Boyd | 9.99% | 4,997,275 |
Source
Related
- Bioxcel Therapeutics, Inc.
- Armistice Capital, LLC
- Bioxcel Therapeutics, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Form 4 · Rodriguez Javier · Jun 17, 2026
- Form 4 · Steinhart Richard I · Jun 17, 2026
- Form 4 · Yocca Frank · Jun 17, 2026
- Form 4 · Mehta Vimal · Jun 17, 2026
- Form 4 · Yocca Frank · May 22, 2026